GAVI recognised as international institution
GAVI recognised as international institution
23 June 2009
The GAVI Alliance, which has been hosted by UNICEF since it was launched in 2000, has become an independent international institution - the first organisation to receive such recognition under the new Swiss Host State Act.
New legal status in Switzerland will help GAVI fulfil its life-saving mission
Dr Julian Lob-Levyt, GAVI CEO (left) and Ambassador Paul Seger, Director of the Department of Public International Law, pictured after signing the agreement by which the Federal Council of Switzerland recognises GAVI's status as an independent international institution. Source: GAVI/2009/Riedo Romano.
Berne, 23 June 2009 - The GAVI Alliance, which has been hosted by UNICEF since it was launched in 2000, has become an independent international institution - the first organisation to receive such recognition under the new Swiss Host State Act.
Under the headquarters agreement signed today on behalf of the Federal Council of Switzerland by Ambassador Paul Seger, Director of the Department of Public International Law, the Geneva-based GAVI Alliance enjoys privileges and immunities similar to those enjoyed by other intergovernmental organisations in Switzerland.
Special ceremony
The agreement was co-signed by Dr Julian Lob-Levyt, Chief Executive Officer of the GAVI Alliance at a special ceremony in Berne.
"We are very grateful to the Swiss government for hosting the GAVI Alliance Secretariat," said Dr Lob-Levyt.
"Through this recognition, Switzerland has shown its full support for our mission to save children's lives and protect people's health by increasing access to immunisation in the world's poorest countries, "said Dr. Julian Lob-Levyt, Chief Executive Officer, GAVI
Public-private partnership
The GAVI Alliance is public-private global health partnership committed to saving children's lives and protecting people's health by increasing access to immunisation in 72 developing countries. It brings together all the main actors in immunisation including developing country and donor governments, the World Health Organization, UNICEF, the World Bank, the vaccine industry in both industrial and developing countries, research and technical agencies, civil society organisations, the Bill & Melinda Gates Foundation and other private philanthropists.
GAVI support consists of providing life-saving vaccines and strengthening health systems. Since 2000, GAVI has disbursed US$ 2 billion enabling 213 million additional children to be vaccinated and more than 3.4 million premature deaths to be averted.
The GAVI Alliance Secretariat at Chemin de Mines in Geneva hosts more than 75 Swiss and international staff, many of whom are recognised as world authorities in their field.
Share this article
Restricted Access Library
The material in this Restricted Access Library is intended to be accessed only by persons with residence within the territory of a Member State of the European Union and is not intended to be viewed by any other persons. The material in this Restricted Access Library is provided by IFFIm for information purposes only and the materials contained herein were accurate only as of their respective dates. Certain information in the materials contained herein is not intended to be, and is not, current. IFFIm accepts no obligation to update any material contained herein.
Persons with residence outside the territory of a Member State of the European Union who have access to or consult any materials posted in this Restricted Access Library should refrain from any action in respect of the securities referred to in such materials and are otherwise required to comply with all applicable laws and regulations in their country of residence.
By clicking Access restricted content: DYNAMIC-LINK-TEXT I confirm that I have read and understood the foregoing and agree that I will be bound by the restrictions and conditions set forth on this page.
The materials in this Restricted Access Library are for distribution only to persons who are not a "retail client" within the meaning of section 761G of the Corporations Act 2001 of Australia and are also sophisticated investors, professional investors or other investors in respect of whom disclosure is not required under Part 6D.2 of the Corporations Act 2001 of Australia and, in all cases, in such circumstances as may be permitted by applicable law in any jurisdiction in which an investor may be located.
The materials in this Restricted Access Library and any documents linked from it are not for access or distribution in any jurisdiction where such access or distribution would be illegal. All of the securities referred to in this Restricted Access Library and in the linked documents have been sold and delivered. The information contained herein and therein does not constitute an offer for sale in the United States or in any other country. The securities described herein and therein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold in the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable state securities laws.
Each person accessing the Restricted Access Library confirms that they are a person who is entitled to do so under all applicable laws, regulations and directives in all applicable jurisdictions. Neither IFFIm nor any of their directors, employees, agents or advisers accepts any liability whatsoever for any loss (including, without limitation, any liability arising from any fault or negligence on the part of IFFIm or its respective directors, employees, agents or advisers) arising from access to Restricted Access Library by any person not entitled to do so.
Reflections on IFFIm: an interview with Rachel Turner
14 November 2024